News

In the long run, onshoring of drug manufacturing in the US might limit WuXi's growth potential for the long run. Read why ...
An award-winning biomedical researcher, entrepreneur and consultant, Gloria Izu, is set to create opportunities for researchers, entrepreneurs, and young professionals in the fields of biotech, ...
The biotech giant's new facility is part of a larger U.S. investment strategy, though it may roll back its buildout if the ...
Pfizer and RemeGen's HER2 antibody-drug conjugate delivered positive phase 3 results in a bladder cancer trial in China. | ...
New research shows the technology’s potential to help find treatments for diseases that have baffled scientists.
The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving insulin.
HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by ...
Fortress subsidiary Checkpoint Therapeutics to be acquired by Sun Pharma; special meeting of Checkpoint stockholders to approve the transaction to take place on May 28, 2025 FDA accepted New Drug ...
Sanofi expects to add “a significant number of high-paying jobs” in the U.S. with $20 billion investment through 2030.
U.S.-based Waters Corp , which makes medical equipment used in clinical testing, has seen a spurt in demand from drugmakers ...
A very different kind of “hog farm” being built by United Therapeutics Corp. on the edge of Stewartville to raise gene-edited ...
Controlling the entire cell therapy production process—from material receipt to product release—is “essential,” according to AstraZeneca, which says its new $300 million manufacturing facility will be ...